💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

China targets margin loans, short selling to help stabilise stocks

Published 02/05/2024, 11:14 AM
Updated 02/05/2024, 12:15 PM
© Reuters. FILE PHOTO: An electronic board shows Hang Seng stock index, at the Lujiazui financial district, following the coronavirus disease (COVID-19) outbreak, in Shanghai, China October 25, 2022. REUTERS/Aly Song

BEIJING (Reuters) - China's securities regulator said on Monday that it would tighten scrutiny of margin financing, malicious short selling and seek to ward off risks involving pledged shares.

The watchdog's vow to stabilise the market comes amid growing concerns that slumping share prices could trigger more selling in a vicious spiral.

The China Securities Regulatory Commission (CSRC) said it would guide brokerages to give investors more time to answer margin calls, so as to ease downward market pressure.

Margin calls require investors to top up collateral for their borrowings, or unwind their leveraged bets.

So far, risks are manageable - forced selling totalled roughly 900 million yuan ($125.03 million) in January - and the watchdog will ensure stable operations of the country's 1.6 trillion margin financing business, the CSRC said.

In a separate statement, the CSRC said it would spur its crackdown on illegal activities that profit from recent market volatility.

"Market manipulation and malicious shorting seriously erode people's wealth, and stand on the opposite camp of individual investors," the CSRC said.

The CSRC vowed "zero tolerance" against ill-intended short sellers, saying those who dare flaunt the law will "lose their shirts and rot in jail".

Regarding worries about major shareholders in China-listed companies who had borrowed against their holdings also facing margin calls, the CSRC said risks were under control.

So far this year, company shareholders have been forced to liquidate pledged shares worth just 27.4 million yuan, which is tiny, the CSRC said.

Although more than 100 major shareholders have supplemented their collateral this year, such activities won't lead to involuntary selling of shares, the watchdog said.

© Reuters. FILE PHOTO: An electronic board shows Hang Seng stock index, at the Lujiazui financial district, following the coronavirus disease (COVID-19) outbreak, in Shanghai, China October 25, 2022. REUTERS/Aly Song

"We will closely monitor the situation and take forceful measures to prevent risks involving pledged shares," the CSRC said.

($1 = 7.1982 Chinese yuan renminbi)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.